热门资讯> 正文
CelloSorbents重新获得纳斯达克最低出价要求合规性
2026-09-23 19:23
- CytoSorbents (CTSO) on Wednesday said it has regained compliance with the Nasdaq Stock Market's minimum bid price requirement.
- On September 22, 2026, CytoSorbents received notification from Nasdaq that it has regained compliance with the minimum bid price requirement as a result of the closing bid price of CytoSorbents' common stock being $1.00 per share or greater for 10 consecutive trading sessions ending September 21, 2026. Accordingly, Nasdaq has determined that this matter is now closed.
- Press release
More on Cytosorbents
- CytoSorbents to execute 1:20 reverse stock split
- Cytosorbents plans to add 3 to 5 Germany sales reps through early 2027 while targeting second-half 2026 operating cash flow breakeven
推荐文章
美股前瞻 | 美国10月CPI全面超预期！美联储沃勒扬言加息50基点；冲刺万亿美元IPO！Anthropic拟募资644亿美元；阿里重磅消息！拟分拆平头哥赴港上市
腾讯Q3盈利料降约5%！资本开支却还要大增？八家华尔街大行齐声唱多，当前股价是否已“跌过头”？
港股异动 | 小摩称市场对存款竞争忧虑或过度，港银股全线拉升！汇丰、渣打齐升3%
华盛早报 | 特朗普释放对伊和平信号！油价重挫6%，费半指数涨近7%；韩股大涨5%触发“熔断”；创新药迎利好，药明康德"军工"标签摘除
美股前瞻 | 特朗普同意停战建议，伊朗据传大让步，布油跌超4%，三大期指齐涨；谷歌推出两款AI芯片挑战英伟达，黄仁勋深陷绯闻调查
华盛早报 | 黄仁勋陷“婚外情”风波！英伟达董事会、美政府已展开调查！欧洲多国抗议数据中心建设；Anthropic估值遭下调至约1.2万亿美元
一周财经日历 | 俄美乌三方会谈、中美通胀数据重磅来袭！ANT估值或缩水至1万亿美元；远信储能领衔7只新股下周上市
美股前瞻 | 特朗普：我100%支持“超级智能”！AI硬件绝地反击，闪迪盘前暴拉11%；10月非农远高于预期！市场加大美联储12月加息押注
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
